发明授权
- 专利标题： NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF
- 专利标题（中）： 新型稠合嘧啶化合物或其盐
-
申请号： EP14836782.4申请日： 2014-08-11
-
公开(公告)号： EP2947086B1公开(公告)日： 2018-01-03
- 发明人: IGUCHI, Satoru , HOSOI, Fumihito , SAGARA, Takeshi
- 申请人： Taiho Pharmaceutical Co., Ltd.
- 申请人地址： 1-27 Kandanishiki-cho Chiyoda-ku Tokyo 101-8444 JP
- 专利权人： Taiho Pharmaceutical Co., Ltd.
- 当前专利权人： Taiho Pharmaceutical Co., Ltd.
- 当前专利权人地址： 1-27 Kandanishiki-cho Chiyoda-ku Tokyo 101-8444 JP
- 代理机构： Hartz, Nikolai
- 优先权： JP2013167600 20130812
- 国际公布： WO2015022926 20150219
- 主分类号： C07D519/00
- IPC分类号： C07D519/00 ; A61K31/519 ; A61P35/00 ; A61P43/00 ; C07D487/04
摘要：
Provided is a novel compound having BTK inhibitory action and a cell proliferation suppressing effect. Also provided is a medicine useful for the prevention and/or treatment of a disease associated with BTK, particularly cancer, based on BTK inhibitory action. A compound represented by formula (I) [wherein R 1 to R 3 , W, A, Y and Z respectively have the meanings as defined in the specification], or a salt thereof is disclosed.
公开/授权文献
- EP2947086A1 NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF 公开/授权日：2015-11-25
信息查询
